FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30937511000001100: Asfotase alfa (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    95546801000001113 Asfotase alfa (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    95546901000001119 Asfotase alfa en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Asfotase alfa Is a Substance with enzyme mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Asfotase alfa 18mg/0.45ml solution for injection vials Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 28mg/0.7ml solution for injection vials Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 40mg/1ml solution for injection vials Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 80mg/0.8ml solution for injection vials Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 18mg/0.45ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 28mg/0.7ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 40mg/1ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 80mg/0.8ml solution for injection vials (Alexion Pharma UK Ltd) Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 80mg/0.8ml solution for injection vials 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 40mg/1ml solution for injection vials 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 28mg/0.7ml solution for injection vials 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Asfotase alfa 18mg/0.45ml solution for injection vials 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 18mg/0.45ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 28mg/0.7ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 40mg/1ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier
    Strensiq 80mg/0.8ml solution for injection vials (Alexion Pharma UK Ltd) 12 vial Has specific active ingredient False Asfotase alfa Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start